首页> Therapeutic advances in drug safety> Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database.

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ali F,Altebainawi

第一单位： Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia.;Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.

作者： Ali F,Altebainawi ^[1] ; Lulwa A,Alfaraj ^[2] ; Amjad A,Alharbi ^[3] ; Fadwa F,Alkhuraisi ^[4] ; Thamir M,Alshammari ^[5]

作者单位： Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia.;Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia. ^[1] Pharmaceutical Care Services, King Khalid Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia. ^[2] Pharmaceutical Care Services, King Salman Specialist Hospital, Hail Health Cluster, Ministry of Health, Hail, Saudi Arabia. ^[3] Pharmaceutical Care Services, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia. ^[4] College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia.;Medication Safety Research Chair, King Saud University, Riyadh 55424, Saudi Arabia. ^[5]

关键词 adverse drug events drug safety pharmacovigilance post-marketing surveillance proton pump inhibitors rhabdomyolysis

DOI 10.1177/20420986231154075

PMID 36875514

发布时间 2023-03-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in drug safety

2023年14卷

20420986231154075页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Therapeutic advances in drug safety

2023年14卷

20420986231154075页

检索历史清除

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database.

Therapeutic advances in drug safety

相似文献

同项目论文

Therapeutic advances in drug safety

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database.

Therapeutic advances in drug safety

相似文献

同项目论文

Therapeutic advances in drug safety

相关期刊

检索历史清除